Hyperkinetic disorders and loss of synaptic downscaling

Nature Neuroscience

Volumn 19, Issue 7, 2016, Pages 868-875

  Calabresi, Paolo ^a,b   Pisani, Antonio ^b,c   Rothwell, John ^d   Ghiglieri, Veronica ^a,b   Obeso, Josè A ^e,f,g   Picconi, Barbara ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e HM Hospitales   (Spain)

^f UNIVERSIDAD SAN PABLO CEU   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL GANGLION; BRAIN CORTEX; BRAIN DEPTH STIMULATION; DYSTONIA; EXCITABILITY; EXCITATORY POSTSYNAPTIC POTENTIAL; EXPERIMENTAL MODEL; HUMAN; HUNTINGTON CHOREA; HYPERKINESIA; LEVODOPA-INDUCED DYSKINESIA; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; STRIATE CORTEX; SYNAPSE; TRANSCRANIAL MAGNETIC STIMULATION; ANIMAL; BRAIN; HUNTINGTON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; BRAIN; DEEP BRAIN STIMULATION; HUNTINGTON DISEASE; NEURONAL PLASTICITY; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84976576381     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4306     Document Type: Review

References (100)

1. Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V., & Di Filippo, M. Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat. Neurosci. 17, 1022-1030 (2014).
2. Malenka, R.C., & Bear, M.F. LTP and LTD: an embarrassment of riches. Neuron 44, 5-21 (2004).
3. Marras C. et al. Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society Task Force. Mov. Disord. 31, 436-457 (2016).
4. Plotkin, J.L., & Surmeier, D.J. Corticostriatal synaptic adaptations in Huntington's disease. Curr. Opin. Neurobiol. 33, 53-62 (2015).
5. Zuccato, C., & Cattaneo, E. Huntington's disease. Handb. Exp. Pharmacol. 220, 357-409 (2014).
6. Quartarone, A., & Pisani, A. Abnormal plasticity in dystonia: disruption of synaptic homeostasis. Neurobiol. Dis. 42, 162-170 (2011).
7. Standaert, D.G. Update on the pathology of dystonia. Neurobiol. Dis. 42, 148-151 (2011).
8. Calabresi, P., Di Filippo, M., Ghiglieri, V., Tambasco, N., & Picconi, B. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. Lancet Neurol. 9, 1106-1117 (2010).
9. Cenci, M.A. Presynaptic mechanisms of l-DOPA-Induced Dyskinesia: the findings, the debate, and the therapeutic implications. Front. Neurol. 5, 242 (2014).
10. Day M. et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 9, 251-259 (2006)
11. Ueno T. et al. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia. Neurobiol. Dis. 64, 142-149 (2014).
12. Raymond, L.A. et al. Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. Neuroscience 198, 252-273 (2011).
13. Galvan, L., André, V.M., Wang, E.A., Cepeda, C., & Levine, M.S. Functional differences between direct and indirect striatal output pathways in Huntington's disease. J. Huntingtons Dis. 1, 17-25 (2012).
14. Picconi B. et al. Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons. Neurobiol. Dis. 22, 143-152 (2006)
15. Plotkin, J.L. et al. Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease. Neuron 83, 178-188 (2014).
16. Milnerwood, A.J., & Raymond, L.A. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load. J. Physiol. (Lond.) 585, 817-831 (2007).
17. Tang, T.S., Chen, X., Liu, J., & Bezprozvanny, I. Dopaminergic signaling and striatal neurodegeneration in Huntington's disease. J. Neurosci. 27, 7899-7910 (2007).
18. Ariano, M.A. et al. Striatal neurochemical changes in transgenic models of Huntington's disease. J. Neurosci. Res. 68, 716-729 (2002).
19. Tarditi A. et al. Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease. Neurobiol. Dis. 23, 44-53 (2006).
20. Giralt A. et al. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Hum. Mol. Genet. 20, 4232-4247 (2011).
21. Varani K. et al. Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages. Neurobiol. Dis. 27, 36-43 (2007).
22. Varani K. et al. Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin. FASEB J. 15, 1245-1247 (2001).
23. Li W. et al. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models. Neurobiol. Dis. 79, 70-80 (2015).
24. Chen, J.Y., Wang, E.A., Cepeda, C., & Levine, M.S. Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility. Front. Neurosci. 7, 114 (2013).
25. Cummings, D.M. et al. Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. Hum. Mol. Genet. 15, 2856-2868 (2006)
26. Murmu, R.P., Li, W., Holtmaat, A., & Li, J.Y. Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease. J. Neurosci. 33, 12997-13009 (2013).
27. Mazzocchi-Jones, D., Döbrössy, M., & Dunnett, S.B. Embryonic striatal grafts restore bi-directional synaptic plasticity in a rodent model of Huntington's disease. Eur. J. Neurosci. 30, 2134-2142 (2009)
28. Albanese A. et al. Phenomenology and classification of dystonia: a consensus update. Mov. Disord. 28, 863-873 (2013).
29. Goodchild, R.E., Grundmann, K., & Pisani, A. New genetic insights highlight 'old' ideas on motor dysfunction in dystonia. Trends Neurosci. 36, 717-725 (2013).
30. Ozelius, L.J. et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 17, 40-48 (1997).
31. Martella G. et al. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 132, 2336-2349 (2009)
32. Grundmann K. et al. Generation of a novel rodent model for DYT1 dystonia. Neurobiol. Dis. 47, 61-74 (2012).
33. Martella G. et al. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia. Neurobiol. Dis. 65, 124-132 (2014).
34. Breakefield, X.O. et al. The pathophysiological basis of dystonias. Nat. Rev. Neurosci. 9, 222-234 (2008).
35. Pisani, A., Bernardi, G., Ding, J., & Surmeier, D.J. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci. 30, 545-553 (2007).
36. Sciamanna G. et al. Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia. J. Neurosci. 32, 11991-12004 (2012).
37. Sciamanna G. et al. Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia. PLoS One 6, e24261 (2011).
38. Napolitano F. et al. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiol. Dis. 38, 434-445 (2010).
39. Dang, M.T. et al. An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice. Behav. Brain Res. 226, 465-472 (2012).
40. Pappas, S.S. et al. Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons. eLife 4, e08352 (2015).
41. Eskow Jaunarajs, K.L., Bonsi, P., Chesselet, M.F., Standaert, D.G., & Pisani, A. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Prog. Neurobiol. 127-128, 91-107 (2015).
42. Fahn, S. The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Mov. Disord. 30, 4-18 (2015).
43. Picconi, B. et al. Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat. Neurosci. 6, 501-506 (2003)
44. Cerovic M. et al. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in l-DOPA-induced dyskinesia. Biol. Psychiatry 77, 106-115 (2015).
45. Picconi B. et al. Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 134, 375-387 (2011).
46. Ghiglieri, V. et al. Modulation of serotonergic transmission by eltoprazine in l-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. Neurobiol. Dis. 86, 140-153 (2016).
47. Thiele, S.L. et al. Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models. Neurobiol. Dis. 71, 334-344 (2014).
48. Fieblinger T. et al. Cell type-specific plasticity of striatal projection neurons in parkinsonism and l-DOPA-induced dyskinesia. Nat. Commun. 5, 5316 (2014).
49. Dumas, E.M. et al. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum. Brain Mapp. 33, 203-212 (2012).
50. Rioult-Pedotti, M.S., Pekanovic, A., Atiemo, C.O., Marshall, J., & Luft, A.R. Dopamine promotes motor cortex plasticity and motor skill learning via PLC activation. PLoS One 10, e0124986 (2015).
51. Ziemann U. et al. Consensus: motor cortex plasticity protocols. Brain Stimul. 1, 164-182 (2008)
52. Abbruzzese G. et al. Intracortical inhibition and facilitation are abnormal in Huntington's disease: a paired magnetic stimulation study. Neurosci. Lett. 228, 87-90 (1997).
53. Priori, A., Berardelli, A., Inghilleri, M., Polidori, L., & Manfredi, M. Electromyographic silent period after transcranial brain stimulation in Huntington's disease. Mov. Disord. 9, 178-182 (1994).
54. Tegenthoff, M., Vorgerd, M., Juskowiak, F., Roos, V., & Malin, J.P. Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington's disease. Electroencephalogr. Clin. Neurophysiol. 101, 298-303 (1996).
55. Schippling S. et al. Abnormal motor cortex excitability in preclinical and very early Huntington's disease. Biol. Psychiatry 65, 959-965 (2009).
56. Crupi D. et al. Cortical and brainstem LTP-like plasticity in Huntington's disease. Brain Res. Bull. 75, 107-114 (2008).
57. Lorenzano C. et al. Motor cortical excitability studied with repetitive transcranial magnetic stimulation in patients with Huntington's disease. Clin. Neurophysiol. 117, 1677-1681 (2006).
58. Orth M. et al. Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease. J. Neurol. Neurosurg. Psychiatry 81, 267-270 (2010).
59. Espay, A.J. et al. Cortical and spinal abnormalities in psychogenic dystonia. Ann. Neurol. 59, 825-834 (2006).
60. Huang, Y.Z., Rothwell, J.C., Lu, C.S., Wang, J., & Chen, R.S. Restoration of motor inhibition through an abnormal premotor-motor connection in dystonia. Mov. Disord. 25, 696-703 (2010).
61. Ridding, M.C., Sheean, G., Rothwell, J.C., Inzelberg, R., & Kujirai, T. Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. J. Neurol. Neurosurg. Psychiatry 59, 493-498 (1995).
62. Brighina F. et al. Effects of cerebellar TMS on motor cortex of patients with focal dystonia: a preliminary report. Exp. Brain Res. 192, 651-656 (2009).
63. Stinear, C.M., & Byblow, W.D. Impaired inhibition of a pre-planned response in focal hand dystonia. Exp. Brain Res. 158, 207-212 (2004).
64. Chen R., & Hallett, M. Focal dystonia and repetitive motion disorders. Clin. Orthop. Relat. Res. 351): 102-106 (1998).
65. Kimberley, T.J. et al. Establishing the definition and inter-rater reliability of cortical silent period calculation in subjects with focal hand dystonia and healthy controls. Neurosci. Lett. 464, 84-87 (2009).
66. Kojovic M. et al. Secondary and primary dystonia: pathophysiological differences. Brain 136, 2038-2049 (2013).
67. Sohn, Y.H., & Hallett, M. Disturbed surround inhibition in focal hand dystonia. Ann. Neurol. 56, 595-599 (2004).
68. Koch G. et al. Altered dorsal premotor-motor interhemispheric pathway activity in focal arm dystonia. Mov. Disord. 23, 660-668 (2008).
69. Quartarone A. et al. Abnormal associative plasticity of the human motor cortex in writer's cramp. Brain 126, 2586-2596 (2003).
70. Weise D. et al. The two sides of associative plasticity in writer's cramp. Brain 129, 2709-2721 (2006).
71. Edwards, M.J., Huang, Y.Z., Mir, P., Rothwell, J.C., & Bhatia, K.P. Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers. Mov. Disord. 21, 2181-2186 (2006).
72. Tamura Y. et al. Disordered plasticity in the primary somatosensory cortex in focal hand dystonia. Brain 132, 749-755 (2009).
73. Tisch S. et al. Pallidal stimulation modifies after-effects of paired associative stimulation on motor cortex excitability in primary generalised dystonia. Exp. Neurol. 206, 80-85 (2007).
74. Ruge D. et al. Shaping reversibility?. Long-term deep brain stimulation in dystonia: the relationship between effects on electrophysiology and clinical symptoms. Brain 134, 2106-2115 (2011).
75. Sadnicka, A., Hamada, M., Bhatia, K.P., Rothwell, J.C., & Edwards, M.J. A reflection on plasticity research in writing dystonia. Mov. Disord. 29, 980-987 (2014).
76. Quartarone A. et al. Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain 132, 2871-2877 (2009)
77. Kang, J.S., Terranova, C., Hilker, R., Quartarone, A., & Ziemann, U. Deficient homeostatic regulation of practice-dependent plasticity in writer's cramp. Cereb. Cortex 21, 1203-1212 (2011).
78. Quartarone A. et al. Homeostatic-like plasticity of the primary motor hand area is impaired in focal hand dystonia. Brain 128, 1943-1950 (2005).
79. Morgante, F., Espay, A.J., Gunraj, C., Lang, A.E., & Chen, R. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 129, 1059-1069 (2006).
80. Huang, Y.Z., Rothwell, J.C., Lu, C.S., Chuang, W.L., & Chen, R.S. Abnormal bidirectional plasticity-like effects in Parkinson's disease. Brain 134, 2312-2320 (2011
81. Fasano, A., & Lozano, A.M. Deep brain stimulation for movement disorders: 2015 and beyond. Curr. Opin. Neurol. 28, 423-436 (2015).
82. Prescott, I.A. et al. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain 132, 309-318 (2009).
83. Prescott, I.A. et al. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia. Neurobiol. Dis. 71, 24-33 (2014
84. Fox, M.D., & Alterman, R.L. Brain stimulation for torsion dystonia. JAMA Neurol. 72, 713-719 (2015).
85. Barow E. et al. Deep brain stimulation suppresses pallidal low frequency activity in patients with phasic dystonic movements. Brain 137, 3012-3024 (2014).
86. Ruge D. et al. Deep brain stimulation effects in dystonia: time course of electrophysiological changes in early treatment. Mov. Disord. 26, 1913-1921 (2011).
87. Prescott, I.A. et al. Reduced paired pulse depression in the basal ganglia of dystonia patients. Neurobiol. Dis. 51, 214-221 (2013).
88. Sharma, M., & Deogaonkar, M. Deep brain stimulation in Huntington's disease: assessment of potential targets. J. Clin. Neurosci. 22, 812-817 (2015).
89. Chou, Y.H., Hickey, P.T., Sundman, M., Song, A.W., & Chen, N.K. Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 72, 432-440 (2015).
90. Udupa, K., & Chen, R. Motor cortical plasticity in Parkinson's disease. Front. Neurol. 4, 128 (2013).
91. Lefaucheur, J.P. et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin. Neurophysiol. 125, 2150-2206 (2014).
92. Koch, G. et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology 65, 623-625 (2005
93. Filipović, S.R., Rothwell, J.C., van de Warrenburg, B.P., & Bhatia, K. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease. Mov. Disord. 24, 246-253 (2009).
94. Koch G. et al. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology 73, 113-119 (2009).
95. Cerasa A. et al. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. Brain 138, 414-427 (2015).
96. Ceballos-Baumann, A.O. et al. Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia. Ann. Neurol. 37, 363-372 (1995).
97. Brusa L. et al. Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients. Ann. Neurol. 58, 655-656 (2005).
98. Shukla, A., Jayarajan, R.N., Muralidharan, K., & Jain, S. Repetitive transcranial magnetic stimulation not beneficial in severe choreiform movements of Huntington disease. J. ECT 29, e16-e17 (2013).
99. Moisello C. et al. TMS enhances retention of a motor skill in Parkinson's disease. Brain Stimul. 8, 224-230 (2015).
100. Udupa K. et al. Cortical plasticity induction by pairing subthalamic nucleus deep-brain stimulation and primary motor cortical transcranial magnetic stimulation in Parkinson's disease. J. Neurosci. 36, 396-404 (2016).